seed
Stage
2023
Founded
1
Investors
About
Cortalix develops synthetic single-domain antibody platforms for PET imaging diagnostics, targeted radiotherapeutics, and CAR-T immunotherapies, offering services from discovery to preclinical applications.
Explore Cortalix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.